Close Menu
    Sales Analysis and Reporting

    Sapiens Reports First Quarter 2024 Financial Results

    By No Comments14 Mins Read
    sapiens

    NEWS PROVIDED BYSapiens International Corporation 

    May 08, 2024, 05:55 ET

    ROCHELLE PARK, N.J., May 8, 2024 /PRNewswire/ — Sapiens International Corporation, (NASDAQ: SPNS) (TASE: SPNS), a leading global provider of software solutions for the insurance industry, today announced its financial results for the first quarter ended March 31, 2024.

    Summary Results for First Quarter 2024 (USD in millions, except per share data)
    GAAPNon-GAAP
    Q1 2024Q1 2023% ChangeQ1 2024Q1 2023% Change
    Revenue$134.2$124.77.6 %$134.2$124.87.6 %
    Gross Profit$57.6$53.08.5 %$60.9$56.48.0 %
    Gross Margin42.9 %42.5 % 40 bps45.4 %45.2 % 20 bps
    Operating Income$20.5$18.98.6 %$24.3$22.57.8 %
    Operating Margin15.3 %15.1 % 20 bps18.1 %18.0 % 10 bps
    Net Income (*)$17.4$14.222.3 %$20.4$17.318.4 %
    Diluted EPS$0.31$0.2619.2 %$0.36$0.3116.1 %
    (*) Attributable to Sapiens’ shareholders

    Roni Al-Dor, President and CEO of Sapiens, stated, “Sapiens delivered a solid first quarter, with year-over-year growth of 7.6% on total revenue of $134 million. The first quarter was highlighted by an impressive 9.5% year-over-year revenue growth in North America. Annualized recurring revenue (ARR) grew year-over-year by 12.7% to $168 million. Operating profit in the first quarter reached $24 million, representing an operating margin of 18.1%.”

    Mr. Al-Dor continued, “New sales are being structured and priced in a SaaS model while we continue to transition current customers to SaaS. Our pivotal partnership with Microsoft, which is unique to the insurance sector, underpins our SaaS strategy and enables the infusion of GenAI capabilities into our solutions, a key differentiator in the industry.”

    “We are well-positioned to continue our positive momentum from the first quarter throughout the remainder of the year,” concluded Mr. Al-Dor. “We are reiterating our 2024 guidance for non-GAAP revenues in a range of $550 million to $555 million and for non-GAAP operating margin in a range of 18.1%-18.5%.”

    Quarterly Results Conference Call

    Management will host a conference call and webcast on May 8, 2024, at 9:30 a.m. Eastern Time (4:30 p.m. in Israel) to review and discuss Sapiens’ results. Please call the following numbers (at least 10 minutes before the scheduled time) to participate:

    • North America (toll-free): 1-888-642-5032
    • International: 972-3-918-0644
    • UK: 0-800-917-5108

    The live webcast of the call can be viewed on Sapiens’ website at: veidan.activetrail.biz/sapiensq1-2024. A replay of the call will be available one business day following the completion of the event, at the same link for 90 days.

    Non-GAAP Financial Measures

    This press release contains the following non-GAAP financial measures: non-GAAP revenue, ARR, non-GAAP gross profit, non-GAAP gross margin, non-GAAP operating income, non-GAAP operating margin, non-GAAP net income attributed to Sapiens shareholders, non-GAAP basic and diluted earnings per share, Adjusted EBITDA and Adjusted Free Cash-Flow.

    Sapiens believes that these non-GAAP measures of financial results provide useful information to management and investors regarding certain financial and business trends relating to Sapiens’ financial condition and results of operations. The Company’s management uses these non-GAAP measures to compare the Company’s performance to that of prior periods for trend analyses, for purposes of determining executive and senior management incentive compensation and for budgeting and planning purposes. These measures are used in financial reports prepared for management and in quarterly financial reports presented to the Company’s board of directors. The Company believes that the use of these non-GAAP financial measures provides an additional tool for investors to use in evaluating ongoing operating results and trends, and in comparing the Company’s financial measures with other software companies, many of which present similar non-GAAP financial measures to investors.

    Non-GAAP financial measures consist of GAAP financial measures adjusted to exclude: Valuation adjustment on acquired deferred revenue, amortization of capitalized software development and other intangible assets, capitalization of software development, stock-based compensation, compensation related to acquisition and acquisition-related costs, restructuring and cost reduction costs, and tax adjustments related to non-GAAP adjustments.

    Management of the Company does not consider these non-GAAP measures in isolation, or as an alternative to financial measures determined in accordance with GAAP. The principal limitation of these non-GAAP financial measures is that they exclude significant expenses and income that are required by GAAP to be recorded in the Company’s financial statements. In addition, they are subject to inherent limitations, as they reflect the exercise of judgment by management about which expenses and income are excluded or included in determining these non-GAAP financial measures.

    To compensate for these limitations, management presents non-GAAP financial measures in connection with GAAP results. Sapiens urges investors to review the reconciliation of its non-GAAP financial measures to the comparable GAAP financial measures, which it includes in press releases announcing quarterly financial results, including this press release, and not to rely on any single financial measure to evaluate the Company’s business.

    Reconciliation tables of the most comparable GAAP financial measures to the non-GAAP financial measures used in this press release are included with the financial tables of this release.

    The Company defines Annual Recurring Revenue (“ARR”) as the annualized value of our revenue from customer subscriptions, term licenses, maintenance, application maintenance, and cloud solutions. The ARR run rate is equal to the product of (i) the sum of these revenues in our most recently completed fiscal quarter, multiplied by (ii) four.

    The Company defines Adjusted EBITDA as net profit, adjusted to eliminate valuation adjustment on acquired deferred revenue, stock-based compensation expense, depreciation and amortization, capitalization of software development costs, compensation expenses related to acquisition and acquisition-related costs, restructuring and cost reduction costs, financial expense (income), provision for income taxes and other income (expenses). These amounts are often excluded by other companies as well, in order to help investors understand the operational performance of their business.

    The Company uses Adjusted EBITDA as a measurement of its operating performance, because it assists in comparing the operating performance on a consistent basis by removing the impact of certain non-cash and non-operating items. Adjusted EBITDA reflects an additional way of viewing aspects of the operations that the Company believes, when viewed with the GAAP results and the accompanying reconciliations to corresponding GAAP financial measures, provide a more complete understanding of factors and trends affecting its business. The Company uses Adjusted Free Cash-Flow as a measurement of its operating performance, and reconciles cash-flow from operating activities to Adjusted Free Cash-Flow, while reducing the amounts for capitalization of software development costs and capital expenditures. The Company adds back cash payments made for former acquisitions in respect of future performance targets and retention criteria as determined upon acquisition date of the respective acquired company, which were included in the cash-flow from operating activities. We believe that Adjusted Free Cash-Flow is useful in evaluating our business, because Adjusted Free Cash-Flow reflects the cash surplus available to fund the expansion of our business.

    About Sapiens

    Sapiens International Corporation (NASDAQ and TASE: SPNS) empowers the financial sector, with a focus on insurance, to transform and become digital, innovative, and agile. With more than 40 years of industry expertise, Sapiens’ cloud-based SaaS insurance platform offers pre-integrated, low-code capabilities across core, data and digital domains to accelerate our customers’ digital transformation. Serving over 600 customers in 30 countries, Sapiens offers insurers across property and casualty, workers’ compensation, and life insurance markets the most comprehensive set of solutions, from core to complementary, including Reinsurance, Financial & Compliance, Data & Analytics, Digital, and Decision Management.  For more information visit www.sapiens.com or follow us on LinkedIn.

    Investor and Media ContactYaffa Cohen-IfrahChief Marketing Officer and Head ofInvestor Relations, SapiensYaffa.cohen-ifrah@sapiens.com+1 917-533-4782   Investors ContactBrett MaasManaging Partner, Hayden IR+1 646-536-7331Brett.Maas@HaydenIR.com Kimberly RogersManaging Director, Hayden IR+1 541-904-5075kim@HaydenIR.com  

    Forward Looking Statements

    Certain matters discussed in this press release are forward-looking statements within the meaning of Section 27A of the Securities Act, Section 21E of the Exchange Act and the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995, and are based on our beliefs, assumptions and expectations, as well as information currently available to us. Such forward-looking statements may be identified by the use of the words “anticipate,” “believe,” “estimate,” “expect,” “may,” “will,” “plan” and similar expressions. Such statements reflect our current views with respect to future events and are subject to certain risks and uncertainties. There are important factors that could cause our actual results, levels of activity, performance or achievements to differ materially from the results, levels of activity, performance or achievements expressed or implied by the forward-looking statements, including, but not limited to: the degree of our success in our plans to leverage our global footprint to grow our sales; the degree of our success in integrating the companies that we have acquired through the implementation of our M&A growth strategy; the lengthy development cycles for our solutions, which may frustrate our ability to realize revenues and/or profits from our potential new solutions; our lengthy and complex sales cycles, which do not always result in the realization of revenues; the degree of our success in retaining our existing customers or competing effectively for greater market share; difficulties in successfully planning and managing changes in the size of our operations; the frequency of the long-term, large, complex projects that we perform that involve complex estimates of project costs and profit margins, which sometimes change mid-stream; the challenges and potential liability that heightened privacy laws and regulations pose to our business; occasional disputes with clients, which may adversely impact our results of operations and our reputation; various intellectual property issues related to our business; potential unanticipated product vulnerabilities or cybersecurity breaches of our or our customers’ systems; risks related to the insurance industry in which our clients operate; risks associated with our global sales and operations, such as changes in regulatory requirements, wide-spread viruses and epidemics like the recent novel coronavirus pandemic, which adversely affected our results of operations, or fluctuations in currency exchange rates; and risks related to our principal location in Israel and our status as a Cayman Islands company. While we believe such forward-looking statements are based on reasonable assumptions, should one or more of the underlying assumptions prove incorrect, or these risks or uncertainties materialize, our actual results may differ materially from those expressed or implied by the forward-looking statements. Please read the risks discussed under the heading “Risk Factors” in our most recent Annual Report on Form 20-F, which we filled with the SEC on March 31, 2022, in order to review conditions that we believe could cause actual results to differ materially from those contemplated by the forward-looking statements. You should not rely upon forward-looking statements as predictions of future events. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee that future results, levels of activity, performance and events and circumstances reflected in the forward-looking statements will be achieved or will occur. Except as required by law, we undertake no obligation to update publicly any forward-looking statements for any reason, to conform these statements to actual results or to changes in our expectations.

    SAPIENS INTERNATIONAL CORPORATION N.V. AND ITS SUBSIDIARIES  
    CONDENSED CONSOLIDATED STATEMENT OF INCOME     
    U.S. dollars in thousands (except per share amounts)
      Three months ended
     March 31,
    20242023
     (unaudited) (unaudited)
     Revenue134,249124,721
     Cost of revenue76,68971,692
     Gross profit57,56053,029
     Operating expenses:
     Research and development, net16,52115,617
     Selling, marketing, general and administrative20,51718,519
     Total operating expenses37,03834,136
     Operating income20,52218,893
     Financial and other expenses (income), net(1,092)1,197
     Taxes on income4,1133,330
     Net income17,50114,366
     Attributable to non-controlling interest141170
     Net income attributable to Sapiens’ shareholders17,36014,196
     Basic earnings per share0.310.26
     Diluted earnings per share0.310.26
    Weighted average number of shares outstanding
    used to compute basic earnings per share (in
    thousands)    		55,74455,156
    Weighted average number of shares outstanding
    used to compute diluted earnings per share (in
    thousands)    		55,98155,570
    SAPIENS INTERNATIONAL CORPORATION N.V. AND SUBSIDIARIES 
    RECONCILIATION OF GAAP TO NON-GAAP RESULTS
    U.S. dollars in thousands (except per share amounts)
    Three months ended
    March 31,
    20242023
    (unaudited)(unaudited)
    GAAP revenue134,249124,721
    Valuation adjustment on acquired deferred revenue–55
    Non-GAAP revenue134,249124,776
    GAAP gross profit57,56053,029
    Revenue adjustment–55
    Amortization of capitalized software1,5451,431
    Amortization of other intangible assets1,7791,848
    Non-GAAP gross profit60,88456,363
    GAAP operating income20,52218,893
    Gross profit adjustments3,3243,334
    Capitalization of software development(1,717)(1,658)
    Amortization of other intangible assets1,2331,076
    Stock-based compensation772863
    Acquisition-related costs (*)1296
    Non-GAAP operating income24,26322,514
      GAAP net income attributable to Sapiens’ shareholders17,36014,196
      Operating income adjustments3,7413,621
      Taxes on income(680)(564)
      Non-GAAP net income attributable to Sapiens’ shareholders20,42117,253
     (*) Acquisition-related costs pertain to charges on behalf of M&A agreements related to future performance targets and
    retention criteria, as well as third-party services, such as tax, accounting and legal rendered until the acquisition date.
    Adjusted EBITDA Calculation
    U.S. dollars in thousands
    Three months ended
     March 31,
    20242023
    GAAP operating profit20,52218,893
    Non-GAAP adjustments:
    Valuation adjustment on acquired deferred revenue–55
    Amortization of capitalized software1,5451,431
    Amortization of other intangible assets3,0122,924
    Capitalization of software development(1,717)(1,658)
    Stock-based compensation772863
    Compensation related to acquisition and acquisition-related costs1296
    Non-GAAP operating profit24,26322,514
    Depreciation1,0971,055
    Adjusted EBITDA25,36023,569
    Summary of NON-GAAP Financial Information 
    U.S. dollars in thousands (except per share amounts)
    Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023
    Revenues134,249130,914130,760128,354124,776
    Gross profit60,88459,37059,26057,99256,363
    Operating income24,26324,15224,05823,41722,514
    Adjusted EBITDA25,36025,26724,77724,39323,569
    Net income to Sapiens’ shareholders20,42120,08119,08018,61017,253
    Diluted earnings per share0.360.360.340.330.31
    Annual Recurring Revenue (“ARR”)
    U.S. dollars in thousands 
    Three months ended
    March 31,
    20242023
    167,646148,729
    Non-GAAP Revenues by Geographic Breakdown
    U.S. dollars in thousands
    Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023
    North America55,15854,88254,84852,11650,371
    Europe68,72765,23964,66262,96064,572
    Rest of the World10,36410,79311,25013,2789,833
    Total134,249130,914130,760128,354124,776
    Non-GAAP Revenue breakdown
    U.S. dollars in thousands
    Q1 2024%Q1 2023%
    Software products and re-occurring post-production services (*)94,24270.20 %81,84265.60 %
    Pre-production implementation services (**)40,00729.80 %42,93434.40 %
    Total Revenues134,249100 %124,776100 %
    Q1 2024Q1 2023
    Software products and re-occurring post-production services (*)50,34044,849
    Pre-production implementation services (**)10,54411,514
    Total Gross profit60,88456,363
    Q1 2024Q1 2023
    Software products and re-occurring post-production services (*)53.40 %54.80 %
    Pre-production implementation services (**)26.40 %26.80 %
    Gross margin45.40 %45.20 %
    (*) Software products and re-occurring post-production services include mainly subscription, term license, maintenance, application maintenance,
    cloud solutions and post-production services. This revenue stream is a mix of recurring and re-occurring in nature..
    (**) Pre-production implementation services include mainly implementation services before go-live, which are one-time in nature. 
    Adjusted Free Cash-Flow
    U.S. dollars in thousands
    Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023
    Cash-flow from operating activities18,48838,6463,98814,60322,188
    Increase in capitalized software development costs(1,717)(1,543)(1,638)(1,679)(1,658)
    Capital expenditures(466)(421)(696)(775)(634)
    Free cash-flow16,30536,6821,65412,14919,896
    Cash payments attributed to acquisition-related costs(*) (**)751221––30
    Adjusted free cash-flow17,05636,9031,65412,14919,926
    (*) Included in cash-flow from operating activities
    (**) Acquisition-related payments pertain to payments on behalf of M&A agreements related to future performance targets and
    retention criteria, as well as third-party services, such as, tax, accounting and legal rendered until the acquisition date.
    SAPIENS INTERNATIONAL CORPORATION N.V. AND ITS SUBSIDIARIES
    CONDENSED CONSOLIDATED BALANCE SHEET
    U.S. dollars in thousands
    March 31,December 31,
    20242023
     (unaudited) (unaudited)
     ASSETS
     CURRENT ASSETS
    Cash and cash equivalents116,689126,716
    Short-term bank deposit79,20075,400
    Trade receivables, net and unbilled receivables103,73590,273
    Other receivables and prepaid expenses19,74122,514
    Total current assets319,365314,903
     LONG-TERM ASSETS
    Property and equipment, net11,98912,661
    Severance pay fund3,3813,605
    Goodwill and intangible assets, net311,178317,352
    Operating lease right-of-use assets21,52423,557
    Other long-term assets16,36217,546
    Total long-term assets364,434374,721
     TOTAL ASSETS683,799689,624
    LIABILITIES AND EQUITY
     CURRENT LIABILITIES
    Trade payables9,7676,291
    Current maturities of Series B Debentures19,79619,796
    Accrued expenses and other liabilities97,49777,873
    Current maturities of operating lease liabilities6,0916,623
    Deferred revenue40,60838,541
    Total current liabilities173,759149,124
     LONG-TERM LIABILITIES
    Series B Debentures, net of current maturities19,75639,543
    Deferred tax liabilities9,15610,820
    Other long-term liabilities11,47411,538
    Long-term operating lease liabilities18,78421,084
    Accrued severance pay7,3687,568
    Total long-term liabilities66,53890,553
    EQUITY443,502449,947
    TOTAL LIABILITIES AND EQUITY683,799689,624
    SAPIENS INTERNATIONAL CORPORATION N.V. AND ITS SUBSIDIARIES
    CONSOLIDATED STATEMENT OF CASH FLOW
    U.S. dollars in thousands
    For the three months ended March 31,
    20242023
    (unaudited)(unaudited)
    Cash flows from operating activities:
    Net income17,50114,366
    Reconciliation of net income to net cash provided by operating activities:
    Depreciation and amortization5,6545,410
    Accretion of discount on series B debentures914
    Capital gain from sale of property and equipment(1)(10)
    Stock-based compensation related to options issued to employees772863
    Net changes in operating assets and liabilities, net of amount acquired:
    Increase in trade receivables, net and unbilled receivables(14,703)(2,039)
    Increase (decrease) in deferred tax liabilities, net(776)25
    Decrease in other operating assets3,7371,257
    Increase (decrease) in trade payables3,547(7,014)
    Increase in other operating liabilities7211,197
    Increase in deferred revenues1,9687,936
    Increase in accrued severance pay, net59183
    Net cash provided by operating activities18,48822,188
    Cash flows from investing activities:
    Purchase of property and equipment(470)(653)
    Investment in deposits(3,291)(45,004)
    Proceeds from sale of property and equipment419
    Capitalized software development costs(1,717)(1,658)
    Acquisition of intellectual property–(177)
    Net cash used in investing activities(5,474)(47,473)
    Cash flows from financing activities:
    Repayment of series B debenture(19,796)(19,796)
    Acquisition of non-controlling interest(3,098)–
    Dividend to non-controlling interest–(47)
    Net cash used in financing activities(22,894)(19,843)
    Effect of exchange rate changes on cash and cash equivalents(147)1,497
    Increase (Decrease) in cash and cash equivalents(10,027)(43,631)
    Cash and cash equivalents at the beginning of period126,716160,285
    Cash and cash equivalents at the end of period116,689116,654

    Debentures Covenants

    As of March 31, 2024, Sapiens was in compliance with all of its financial covenants under the indenture for the Series B Debentures, based on having achieved the following in its consolidated financial results:

    Covenant 1 

    • Target shareholders’ equity (excluding non-controlling interest): above $120 million.
    • Actual shareholders’ equity (excluding non-controlling interest) equal to $443.5 million.

    Covenant 2

    • Target ratio of net financial indebtedness to net capitalization (in each case, as defined under the indenture for the Company’s Series B Debentures) below 65%.
    • Actual ratio of net financial indebtedness to net capitalization equal to (54.35)%.

    Covenant 3

    • Target ratio of net financial indebtedness to EBITDA (accumulated calculation for the four last quarters) is below 5.5.
    • Actual ratio of net financial indebtedness to EBITDA (accumulated calculation for the four last quarters) is equal to (1.56).

    Logo – https://mma.prnewswire.com/media/585787/Sapiens_Logo.jpg

    SOURCE Sapiens International Corporationrt

    Related Posts

    Add A Comment
    Leave A Reply